Assignee
SHAW GRAY D
US·6 granted patents·2 pending applications·10 citations·filing 2007–2022
Top patents by PatentIndex Score
8 records- 0192US12195518B2Methods for treating cancer using soluble forms of PSGL-1 and fusion molecules thereofSHAW GRAY D·Filed 2022·Granted Jan 14, 2025·1 cites·16 claims
- 0285US8889628B2Soluble tandem selectin glycoprotein ligand moleculesSHAW GRAY D·Filed 2012·Granted Nov 18, 2014·8 cites·12 claims
- 0373US10214578B1Variants of IgG-Fc fusion that provide for site-specific conjugation at the N-terminusSHAW GRAY D·Filed 2016·Granted Feb 26, 2019·1 cites·16 claims
- 0468US12479904B2Methods of treating cytokine release syndrome by administering a molecule comprising a soluble tandem selectin glycoprotein ligandSHAW GRAY D·Filed 2018·Granted Nov 25, 2025·0 cites·16 claims
- 0557US2007274999A1Method of treating disorders using platelet glycoprotein Ib alpha fusion polypeptidesSHAW GRAY D·Filed 2007·Application pending·0 cites
- 0654US2023303657A1Fusion Molecules of PSGL-1 or TSGL Anionic Domains to Checkpoint-Modulating Antibodies and Other AntibodiesSHAW GRAY D·Filed 2021·Application pending·0 cites
- 0747US10421796B2Variants of IgG Fc with limited amine groupsSHAW GRAY D·Filed 2015·Granted Sep 24, 2019·0 cites·7 claims
- 0841US9266923B2Compositions and methods for treatment of thrombosis and for prolonging survival of stored plateletsSHAW GRAY D·Filed 2011·Granted Feb 23, 2016·0 cites·20 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →